🌟 Join Us for the Second Oncothon! 🌟On February 15, International Childhood Cancer Day, we are coming together to raise vital funds for pediatric cancer research. 🎗️@GevorgTamamyan OncoDaily Maria (Masha) Babak, PhD #Oncothon #ChildhoodCancer #PediatricResearch #MakeADifference

🎗️At the Second Global OncoThon by OncoDaily, Jemma Arakelyan (Jemma Arakelyan), Medical Oncologist and CEO at the Institute of Cancer and Crisis (Institute of Cancer and Crisis), shared her heartfelt perspective on the challenges faced by young cancer patients, reflecting on her experiences

Thrilled to announce our new publication in Pharmaceutics: "Exploring the Anticancer Potential of NO-Donor Oxadiazole Assemblies Against Malignant Pleural Mesothelioma"! 🎉 We've developed novel NO-donor compounds showing exceptional promise against MPM. These compounds

Interesting..#spatiaoncology

Check out our recent publication in #JACS ! The Babak Lab HK Maria (Masha) Babak, PhD

Choose the hard way; you'll face fewer competitors and build greater strength. ✨ #Motivation #Success #HardWork #SuccessMindset #HongKong MTR Service Update

🎙️A Journey of Hope: Norman Ng’s Inspiring Story In this episode of OncoInfluencers, Jemma Arakelyan interviews Norman Ng, a lung cancer survivor and Director of Patient Advocacy at Healthcare Thinkers. Norman shares his personal journey with stage 4 lung cancer, his work

Gut microbiota from Phase III JCOG2007 (NIPPON) trial of 1L pembro/chemo vs nivo + ipi/chemo in NSCLC JTO & JTO CRR. Fusicatenibacter & Butyricicoccus associated with longer OS, fewer AEs, more benefit with nivo/ipi. Microbiome impact could be massive. jto.org/article/S1556-…

This truly feels like a dream come true. I will be attending the Lindau Meeting with #NobelPrize winners!  A huge thank you to my mentor Maria (Masha) Babak, PhD, City University of Hong Kong and #theCroucherFoundation for making this possible!

Just visited the HK Herbarium and it was fascinating! 🌿 The variety of plant specimens and the dedication to preserving biodiversity is truly impressive. Highly recommend checking it out! The Babak Lab HK #HKHerbarium #NatureExploration

This is my first faculty invitation from ASCO ! Looking forward to learning and contributing my humble presence. The ASCO Post 🌟 #ASCO2025 #Grateful #CancerResearch #GlobalCancerCare #ICC

ASPIRE for Lung Cancer - Successfully concluded the second workshop of the APAC Lung Cancer Policy Consensus initiative Herbert Loong, MBBS, FASCO Asia Pacific Coalition against Lung Cancer Sewanti Limaye 🇮🇳🇺🇸 Dr. Abhishek Shankar, MD, CPFP(NCI, USA), MBA Jemma Arakelyan Hidehito HORINOUCHI oncodaily.com/url/268420 #LungCancer #ASPIRE #APAC #Cancer #OncoDaily

Thank you, TouchMedicalGroup, for highlighting my story in the #FutureOncologyLeaders Corner! touchoncology.com/insight/dr-jem…

Jemma Arakelyan: Insights on the trial of Balstilimab + Botensilimab in Metastatic NSCLC Jemma Arakelyan Immune Oncology Research Institute oncodaily.com/science/jemma-… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedEd #MedNews #Balstilimab #Botensilimab #NSCLC

🌟 #FutureLeader2025 Dr Jemma Arakelyan on how personal loss fuels her mission to drive innovation & compassion in oncology care. 📖 Read her story: touchoncology.com/insight/dr-jem… Jemma Arakelyan #FutureLeaders2025 #OncologyLeadership #PrecisionMedicine #WomenInOncology

🧬 MSI-H = hallmark of mismatch repair (MMR) deficiency. 🧵 Prevalence: ~30% endometrial, ~10% CRC, ~8% gastric. But not all MSI-H/dMMR tumors are alike: 1️⃣ MSH2/MSH6 loss → ↑ TMB, better ICI response 2️⃣ PTEN/AKT1 mutations → ICI resistance Checkpoint blockade is now 1L in CRC

🚀 Very progressive content in education: social annotations by Prof. Gavin Porter from Harvard University. Check out #perusall #EdTech #ProgressiveEducation

Thanks to my friend Norman Ng, I had the privilege of meeting Dr. Hui Pun, a true visionary in medical oncology - Jemma Arakelyan oncodaily.com/url/296381 #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

Ready to learn, share, and connect at ASCO 2025 - Jemma Arakelyan ASCO oncodaily.com/blog/asco-2 #ASCO2025 #Cancer #InstituteOfCancerAndCrisis #OncoDaily #Oncology #MedEd #MedX

Agree! No spoilers please ! ASCO